Pharma

Fostering a diverse, inclusive work environment for LGBTQ talent

Fostering a diverse, inclusive work environment for LGBTQ talent

According to a 2014 study conducted by The Human Rights Campaign, the largest LGBTQ civil rights advocacy group in the U.S., 53% of all LGBTQ workers nationwide "hide who they are in the workplace."

Lions Health: 2018 pharma winners

Lions Health: 2018 pharma winners

Here are the Lions Health winners in the pharma category.

No pharma Grand Prix awarded for second straight year

No pharma Grand Prix awarded for second straight year

By

Since the inception of the award in 2014, the pharma Grand Prix has only been awarded twice.

Confusion expected in wake of 'Right to Try' bill's signing

Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

Is it time for pharma ad agencies to reboot?

Is it time for pharma ad agencies to reboot?

As global advertisers cut their spending, should the agency world take a hard look in the mirror?

We asked for your take on pharma's diversity push. Here are the responses

We asked for your take on pharma's diversity push. Here are the responses

MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.

Five things for pharma marketers to know: Monday, June 4, 2018

Five things for pharma marketers to know: Monday, June 4, 2018

By

New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

By

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

How drugmakers are facing the entrance of consumer giants into healthcare

How drugmakers are facing the entrance of consumer giants into healthcare

By

As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Experts skeptical feds' move on Insys will tilt scales of justice against opioid maker

Insys founder John Kapoor has maintained his innocence in the face of charges.

Alisa Lask, Galderma

Alisa Lask, Galderma

Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.

Elena Cant, Takeda

Elena Cant, Takeda

Elena Cant is VP, global head of vaccine commercial, Takeda Vaccine Business Unit of Takeda.

Meghan Rivera, Amag Pharmaceuticals

Meghan Rivera, Amag Pharmaceuticals

Meghan Rivera is VP, digital customer engagement of Amag Pharmaceuticals.

Wendy Blackburn, Intouch Solutions

Wendy Blackburn, Intouch Solutions

Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.

Deborah Profit, Ostuka

Deborah Profit, Ostuka

Deborah Profit is VP, Otsuka Information Technology at Ostuka.

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

By

Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

By

Here's a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen's firm.

Evidence-based patient access programs

Evidence-based patient access programs

By

At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.

Interview | Paul LeVine, TrialCard

Interview | Paul LeVine, TrialCard

By

Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.

GSK reviews $1.76 billion global media

GSK reviews $1.76 billion global media

By

Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.

Trust in health sector takes a hit in major markets, Edelman research finds

Trust in health sector takes a hit in major markets, Edelman research finds

By

The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.

Interview | Gary Scheiner, GHG

Interview | Gary Scheiner, GHG

By

Gary Scheiner, EVP and chief creative officer at GHG, discusses the inherent tension in day-to-day marketing for healthcare brands.

Marketers share how they use ad safety tech to help pharma clients feel comfortable

Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.

How pharma and healthcare shifted strategies post-blockbuster drug success

How pharma and healthcare shifted strategies post-blockbuster drug success

Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.

Drugs' value to patients eclipsed by price tags

Drugs' value to patients eclipsed by price tags

Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.

Agencies enable staff to find well-being through work

Agencies enable staff to find well-being through work

By

Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.

Health brands need to consider the human side of patients, HCPs, and stakeholders

Health brands need to consider the human side of patients, HCPs, and stakeholders

Croom Lawrence and Kent Groves of Merkle Health explain being human.